Xebio Holdings Co., Ltd.
Stock Option Grant Decision｜June 2026
Xebio Holdings will allocate 2,180 stock acquisition rights to 58 individuals on June 12, 2026, with an exercise period from June 13, 2028, to June 12, 2033. The purpose is to incentivize performance improvement and increase corporate value.
Key Figures
- Number of stock acquisition rights allotted: 2,180 shares
- Allotment scheduled date: June 12, 2026
- Exercise period: From June 13, 2028, to June 12, 2033
AI要約
Details of the Stock Acquisition Rights Issuance
Xebio Holdings resolved at the Board of Directors meeting held on June 5, 2026, to allocate 2,180 stock acquisition rights to 58 individuals on June 12, 2026. The purpose is to incentivize directors and employees to improve performance and increase corporate value, with the exercise period from June 13, 2028, to June 12, 2033. No payment is required for exercise, and the number of shares and exercise price may be adjusted.
Purpose and Future Outlook
This stock acquisition rights issuance aims to enhance motivation among employees and officers and to increase corporate value. While it may lead to shareholder dilution, it is expected to contribute to long-term corporate value enhancement. The allotment has not yet been exercised, and future exercise and impact will depend on stock price movements and performance.
Xebio Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
